Benitec Biopharma stockholders elect directors and approve preferred stock authorization at 2024 annual meeting

Benitec Biopharma Inc.

Directors J. Kevin Buchi and Peter Francis elected with 17.3M and 16.5M votes respectively.
Ratification of independent auditor passed with 17,978,704 votes for, 260 against.
Advisory vote on executive compensation approved with 17,307,680 votes for.
Amendment to authorize up to 5,000,000 shares of preferred stock approved with 15,313,718 votes for (85% of votes cast).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.